Involvement of growth factors in the pathophysiology of polycystic ovary syndrome.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Gynecological Endocrinology

• Publication date

  1998-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3109/09513599809012841PMID 10065164
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cohort size rather than follicle-stimulating hormone threshold level determines ovarian sensitivity in polycystic ovary syndrome.

  1998cited by this paper
• Serum vascular endothelial growth factor concentrations and ovarian stromal blood flow are increased in women with polycystic ovaries.

  1998cited by this paper
• Hyperexpression of epidermal growth factor receptors in granulosa cells from women with polycystic ovary syndrome.

  1998cited by this paper
• The genetic basis of polycystic ovary syndrome.

  1997cited by this paper
• Insulin-Like Growth Factor Binding Proteins: Do They Play A Role in Polycystic Ovary Syndrome?

  1997cited by this paper
• The developmental potential of the human oocyte is related to the dissolved oxygen content of follicular fluid: association with vascular endothelial growth factor levels and perifollicular blood flow characteristics.

  1997cited by this paper
• Role of Growth Hormone in Polycystic Ovarian Syndrome

  1997cited by this paper
• Growth differentiation factor-9 is required during early ovarian folliculogenesis

  1996cited by this paper
• Targeted overexpression of Bcl-2 in ovaries of transgenic mice leads to decreased follicle apoptosis, enhanced folliculogenesis, and increased germ cell tumorigenesis.

  1996cited by this paper
• Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.

  1996cited by this paper
• Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome.

  1996cited by this paper
• Serum levels of insulin-like growth factor-1, IGF binding protein-1 and insulin and the response to human menopausal gonadotrophins in women with polycystic ovary syndrome.

  1996cited by this paper
• Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome.

  1995cited by this paper
• Effects of epidermal growth factor, transforming growth factor alpha and androstenedione on follicular growth and aromatization in culture.

  1995cited by this paper
• Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients.

  1995cited by this paper
• Effects of epidermal growth factor, transforming growth factor α and androstenedione on follicular growth and aromatization in culture

  1995cited by this paper
• Expression of vascular permeability factor/vascular endothelial growth factor by human granulosa and theca lutein cells. Role in corpus luteum development.

  1995cited by this paper
• Ovulation induction: Effects of ovulation induction with gonadotrophins on the ovary and uterus and their implications for assisted reproduction

  1995cited by this paper
• Production of transforming growth factor-alpha by normal and polycystic ovaries.

  1995cited by this paper
• Serine phosphorylation of human P450c17 increases 17,20-lyase activity: implications for adrenarche and the polycystic ovary syndrome.

  1995cited by this paper
• Overexpression of a human transforming growth factor-alpha (TGF alpha) transgene reveals a dual antagonistic role of TGF alpha in female sexual development.

  1994cited by this paper
• Estradiol production by granulosa cells of normal and polycystic ovaries: relationship to menstrual cycle history and concentrations of gonadotropins and sex steroids in follicular fluid.

  1994cited by this paper
• Hypersecretion of androstenedione by isolated thecal cells from polycystic ovaries.

  1994cited by this paper
• Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy.

  1994cited by this paper
• Expression of epidermal growth factor and its receptor in the human ovary during follicular growth and regression.

  1993cited by this paper
• Epidermal growth factor and basic fibroblast growth factor suppress the spontaneous onset of apoptosis in cultured rat ovarian granulosa cells and follicles by a tyrosine kinase-dependent mechanism.

  1992cited by this paper
• Twenty-four-hour serum growth hormone, insulin, C-peptide and blood glucose profiles and serum insulin-like growth factor-I concentrations in women with polycystic ovaries.

  1992cited by this paper
• Evidence for Distinctive and Intrinsic Defects in Insulin Action in Polycystic Ovary Syndrome

  1992cited by this paper
• Women with polycystic ovary syndrome wedge resected in 1956 to 1965: a long-term follow-up focusing on natural history and circulating hormones.

  1992cited by this paper
• The role of insulin-like growth factor-1 (IGF-1) and IGF binding protein-1 (IGFBP-1) in the pathogenesis of polycystic ovary syndrome.

  1992cited by this paper
• Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome.

  1992cited by this paper
• Women with polycystic ovary syndrome wedge resected in 1956 to 1965: A long‐term follow‐up focusing on natural history and circulating hormones

  1992cited by this paper
• Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome

  1992cited by this paper
• Follicular fluid steroid and epidermal growth factor content, and in vitro estrogen release by granulosa-luteal cells from patients with polycystic ovaries in an IVF/ET program.

  1991cited by this paper
• Short and long term effects of growth hormone on circulating levels of insulin-like growth factor-I (IGF-I), IGF-binding protein-1, and insulin: a placebo-controlled study.

  1991cited by this paper
• EFFECTS OF LUTEINIZING HORMONE, INSULIN, INSULIN‐LIKE GROWTH FACTOR‐I AND INSULINLIKE GROWTH FACTOR SMALL BINDING PROTEIN 1 IN THE POLYCYSTIC OVARY SYNDROME

  1990cited by this paper
• Epidermal growth factor influences growth and differentiation of rat granulosa cells.

  1990cited by this paper
• Dysregulation of cytochrome P450c 17 alpha as the cause of polycystic ovarian syndrome.

  1990cited by this paper
• INHIBITION OF OESTRADIOL PRODUCTION BY EPIDERMAL GROWTH FACTOR IN HUMAN GRANULOSA CELLS OF NORMAL AND POLYCYSTIC OVARIES

  1990cited by this paper
• Dysregulation of cytochrome P450c17α as the cause of polycystic ovarian syndrome

  1990cited by this paper
• Most women with acne have polycystic ovaries

  1989cited by this paper
• Profound Peripheral Insulin Resistance, Independent of Obesity, in Polycystic Ovary Syndrome

  1989cited by this paper
• Epidemiology of infertility and polycystic ovarian disease: endocrinological and demographic studies.

  1987cited by this paper
• Multifollicular ovaries: Clinical and endocrine features and response to pulsatile gonadotropin releasing hormone

  1987cited by this paper
• Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism.

  1986cited by this paper
• Somatomedin-C enhances induction of luteinizing hormone receptors by follicle-stimulating hormone in cultured rat granulosa cells.

  1985cited by this paper
• Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotropin releasing hormone.

  1985cited by this paper
• Morphology and Morphogenesis of the Stein-Leventhal Ovary and of So-called “Hyperthecosis”

  1982cited by this paper
• Morphology and morphogenesis of the Stein-Leventhal ovary and of so-called "hyperthecosis".

  1982cited by this paper
• Stature and the Gynecologist.

  1977cited by this paper

• CTBP1 links metabolic syndrome to polycystic ovary syndrome through interruption of aromatase and SREBP1

  2024cites this paper
• MicroRNA-135a Regulates VEGFC Expression and Promotes Luteinized Granulosa Cell Apoptosis in Polycystic Ovary Syndrome

  2020cites this paper
• Effects of methoxychlor on IGF-I signaling pathway in rat ovary

  2017cites this paper
• Altered expression of transforming growth factor-beta isoforms in bovine cystic ovarian disease.

  2014cites this paper
• Altered gene expression profile in cumulus cells of mature MII oocytes from patients with polycystic ovary syndrome.

  2012cites this paper
• mRNA expression pattern of insulin-like growth factor components of granulosa cells and cumulus cells in women with and without polycystic ovary syndrome according to oocyte maturity.

  2010cites this paper
• Androgen circle of polycystic ovary syndrome.

  2009cites this paper
• Influence of dichlorodiphenylchloroethylene on vascular endothelial growth factor and insulin-like growth factor in human and rat ovarian cells.

  2007cites this paper
• Gonadotropin and intra-ovarian signals regulating follicle development and atresia: the delicate balance between life and death.

  2007cites this paper
• GH-binding protein is related to bone mineral density in non-obese androgenized women

  2006cites this paper
• Serum and follicular fluid levels of soluble Fas, soluble Fas ligand and apoptosis of luteinized granulosa cells in PCOS patients undergoing IVF.

  2005cites this paper
• The pathogenesis of infertility and early pregnancy loss in polycystic ovary syndrome.

  2004cites this paper
• Growth hormone secretion is impaired but not related to insulin sensitivity in non-obese patients with polycystic ovary syndrome.

  2004influential citation
• Insulinoma presenting with hyperandrogenism: a case report and a literature review

  2003cites this paper
• Transforming growth factor‐beta isoform expression during bovine ovarian antral follicle development

  2003cites this paper
• Regulation of cell death and cell survival gene expression during ovarian follicular development and atresia.

  2003influential citation
• GH-IGF-I axis in non-obese women with functional hyperandrogenism

  2002cites this paper
• Expression of Insulin-Like Growth Factor (IGF), IGF Receptor, and IGF-Binding Protein Messenger Ribonucleic Acids in Luteinized Granulosa Cells from Different Size Follicles After Controlled Ovarian Hyperstimulation

  2002cites this paper
• Low amplitude and disorderly spontaneous growth hormone release in obese women with or without polycystic ovary syndrome.

  2002cites this paper
• Involvement of Transforming Growth Factor α in the Regulation of Rat Ovarian X-Linked Inhibitor of Apoptosis Protein Expression and Follicular Growth by Follicle-Stimulating Hormone1

  2002cites this paper
• Polycystic ovary syndrome, androgen excess, and the impact on bone.

  2001cites this paper
• Follistatin and activin A serum concentrations in obese and non-obese patients with polycystic ovary syndrome.

  2001cites this paper
• Clinical Review 116: Bone mineral density, androgens, and the polycystic ovary: the complex and controversial issue of androgenic influence in female bone.

  2000cites this paper